Policy Brief
⭐ 4.5
Clinical Trials and Data Quality And Bias among Pharmaceutical Firms — Post-Pandemic Lessons
Abstract
This policy brief investigates “Clinical Trials and Data Quality And Bias among Pharmaceutical Firms — Post-Pandemic Lessons” using a social network analysis. Through a institutional lens, the analysis integrates multi-source data to derive a stakeholder-aligned blueprint for researchers and practitioners.